MBCL-36. HOW TO INCREASE SURVIVAL IN 7 TO 10% OF PATIENTS WITH AVERAGE-RISK MEDULLOBLASTOMA WITHOUT NEW THERAPIES: EARLY PROSPECTIVE NEURORADIOLOGY SCREENING EXPERIENCE FROM THE CHILDREN’S ONCOLOGY GROUP

BACKGROUND: Previous Children’s Oncology Group (COG) average-risk medulloblastoma studies retrospectively identified that 7 to 10% of patients were wrongly staged; either due to the presence of unequivocal residual disease greater than 1.5cm(2) or metastatic disease. Notably, these patients had an i...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Gottardo, Nicholas, Leary, Sarah, Kang, Guolian, Gossett, Jeffrey, Fouladi, Maryam, Kessel, Sandy, Sabin, Noah, Jaju, Alok, Harreld, Julie
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Medulloblastoma (Clinical)
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715223/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.512
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы